It has been two years since the Polish launch of a large scale research project set to determine the role of early invasive diagnostics and coronary revascularization in patients with stable coronary artery disease and significant myocardial ischemia on stress testing. The ISCHEMIA Trial is one or the largest multinational, randomized trial sponsored by the American National Heart, Lung, and Blood Institute (NHLBI).
On 1 Jan 2015, it has been five years since the Institute of Cardiology Unit for Screening Studies in Inherited Cardiovascular Diseases (USSICD) was established. Since 19 Mar 2014 the USSICD has been operating in its own separate location. There are 2147 patients and their relatives registered in the Unit. The largest groups of patients and their relatives with dilated cardiomyopathy (n=616), with aneurysm and thoracic aortic dissection (n=520), and other cardiomyopathies (n=306).
We wish to inform you that the Unit for Screening Studies in Inherited Cardiovascular Diseases (USS-ICVD), which has been functioning since the 1st of January 2010, has been transferred to a new location. The place looks modern and adheres to high standards that meet all relevant EU recommendations for health care facilities.
A modern, fully equipped hybrid operating room has been launched at the Institute of Cardiology, Warsaw.
A hybrid room is a platform of cooperation between interventional cardiologists and cardiosurgeons. It enables a multidisciplinary Heart Team to treat simultaneously the heart and large vessels. Such an approach is recommended by both the European Society of Cardiology and the Polish Cardiac Society.
There have been other minimally invasive cardiac procedures performed at the Institute of Cardiology Department of Cardiac Surgery and Transplantology. They included mitral valvuloplasty and closing of a superior vena cava-type atrial septal defect .Operations of this type are carried out through an approximately 2-inch incision in the chest wall (minithoracotomy).